Showing results (101-110 of 123) with videos related to

Sort By:
Pageof 13
Muscle & Nerve|April 25, 2020
Spinal muscular atrophy care in the COVID-19 pandemic eraAravindhan Veerapandiyan, Anne M Connolly, Richard S Finkel, et al.
Birth Defects Research. Part A, Clinical and Molecular Teratology|October 13, 2006
The muscular Dystrophy Surveillance Tracking and Research Network (MD STARnet): surveillance methodologyLisa A Miller, Paul A Romitti, Christopher Cunniff, et al.
JAMA|October 4, 2012
Mexiletine for symptoms and signs of myotonia in nondystrophic myotonia: a randomized controlled trialJeffrey M Statland, Brian N Bundy, Yunxia Wang, et al.
Muscle & Nerve|April 25, 2020
The care of patients with Duchenne, Becker, and other muscular dystrophies in the COVID-19 pandemicAravindhan Veerapandiyan, Kathryn R Wagner, Susan Apkon, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 19, 2020
Implementation of population-based newborn screening reveals low incidence of spinal muscular atrophyDenise M Kay, Colleen F Stevens, April Parker, et al.
Neurology|July 14, 2022
Newborn Screening for Spinal Muscular Atrophy in New York State: Clinical Outcomes From the First 3 YearsBo Hoon Lee, Stella Deng, Claudia A Chiriboga, et al.
Plos One|October 19, 2020
Medical management of muscle weakness in Duchenne muscular dystrophySarah R Rivera, Sumit K Jhamb, Hoda Z Abdel-Hamid, et al.
Neurology|February 12, 2016
Randomized, placebo-controlled trials of dichlorphenamide in periodic paralysisValeria A Sansone, James Burge, Michael P McDermott, et al.
Muscle & Nerve|November 5, 2020
Association of genetic mutations and loss of ambulation in childhood-onset dystrophinopathyGregory Haber, Kristin M Conway, Pangaja Paramsothy, et al.
Pediatrics|February 18, 2015
Prevalence of Duchenne and Becker muscular dystrophies in the United StatesPaul A Romitti, Yong Zhu, Soman Puzhankara, et al.
Pageof 13